•• Helle AC, Watts AL, Trull TJ, Sher KJ. Alcohol use disorder and antisocial and borderline personality disorders. Alcohol Res Curr Rev. 2019;40:35–50. Review of co-occurring alcohol use disorder and antisocial and borderline personality disorders, with an emphasis on theoretical explanations, outcomes, and treatments.
Kienast T, Stoffers J, Bermpohl F, Lieb K. Borderline personality disorder and comorbid addiction. Dtsch Arztebl Int. 2014;111(16):280–6.
PubMed PubMed Central Google Scholar
Parmar A, Kaloiya G. Comorbidity of personality disorder among substance use disorder patients: a narrative review. Indian J Psychol Med. 2018;40(6):517–27.
Article PubMed PubMed Central Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. [Internet]. 5th edition. Arlington, VA: American Psychiatric Association; 2013 [cited 2023 Jun 21]. 947 p.
Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010;24(4):412–26.
Article PubMed PubMed Central Google Scholar
Substance Abuse and Mental Health Services Administration (SAMHSA). 2021 NSDUH Annual National Report | CBHSQ Data [Internet]. 2021 [cited 2023 Jun 22]. Available from: https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report
Guy N, Newton-Howes G, Ford H, Williman J, Foulds J. The prevalence of comorbid alcohol use disorder in the presence of personality disorder: systematic review and explanatory modelling. Personal Ment Health. 2018;12(3):216–28.
Kuo CJ, Chen WY, Tsai SY, Chen PH, Ko KT, Chen CC. Excessive mortality and causes of death among patients with personality disorder with comorbid psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol. 2019;54(1):121–30.
• Hanna Chaim C, Santana GL, de Vries Albertin P, Silveira CM, Siu ER, Viana MC, et al. Alcohol use patterns and disorders among individuals with personality disorders in the Sao Paulo Metropolitan Area. PLoS One. 2021;16(3):e0248403. Cross-sectional study of prevalence of alcohol use disorder and patterns among 2942 Brazilian adults in Brazil, which found Cluster B PDs to be particularly associated with alcohol.
González E, Arias F, Szerman N, Vega P, Mesias B, Basurte I. Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology. Actas Esp Psiquiatr. 2019;47(6):218–28.
Trull TJ, Freeman LK, Vebares TJ, Choate AM, Helle AC, Wycoff AM. Borderline personality disorder and substance use disorders: an updated review. Borderline Personality Disord Emot Dysregulation. 2018;5(1):15.
Article PubMed PubMed Central Google Scholar
Sher L, Rutter SB, New AS, Siever LJ, Hazlett EA. Gender differences and similarities in aggression, suicidal behaviour, and psychiatric comorbidity in borderline personality disorder. Acta Psychiatr Scand. 2019;139(2):145–53.
Scalzo F, Hulbert CA, Betts JK, Cotton SM, Chanen AM. Substance use in youth with borderline personality disorder. J Pers Disord. 2018;32(5):603–17.
Scalzo F, Hulbert CA, Betts JK, Cotton SM, Chanen AM. Predictors of substance use in youth with borderline personality disorder. Personal Disord. 2018;9(4):390–6.
Howard R, Hasin D, Stohl M. Substance use disorders and criminal justice contact among those with co-occurring antisocial and borderline personality disorders: findings from a nationally representative sample. Personal Ment Health. 2021;15(1):40–8.
Mundt AP, Baranyi G. The unhappy mental health triad: comorbid severe mental illnesses, personality disorders, and substance use disorders in prison populations. Front Psychiatry. 2020;11:804.
Article PubMed PubMed Central Google Scholar
Holzer KJ, Vaughn MG, Loux TM, Mancini MA, Fearn NE, Wallace CL. Prevalence and correlates of antisocial personality disorder in older adults. Aging Ment Health. 2022;26(1):169–78.
Puddephatt JA, Jones A, Gage SH, Fear NT, Field M, McManus S, et al. Associations of alcohol use, mental health and socioeconomic status in England: findings from a representative population survey. Drug Alcohol Depend. 2021;1(219): 108463.
Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58(6):590–6.
Hochheimer M, Sacco P, Ware OD. Latent classes of lifetime drug use disorder in national epidemiological survey on alcohol and related conditions - III. Addict Behav. 2020;106: 106379.
Carpenter RW, Wood PK, Trull TJ. Comorbidity of borderline personality disorder and lifetime substance use disorders in a nationally representative sample. J Pers Disord. 2016;30(3):336–50.
Rhee TG, Rosenheck RA. Gender differences in psychiatric and behavioral health burden among adults with alcohol and other substance use disorders in the United States. J Addict Med. 2022;16(3):295–302.
Cavicchioli M, Prudenziati F, Movalli M, Ramella P, Maffei C. The severity of personality pathology: a risk factor for concurrent substance use disorders in alcohol use disorder. J Dual Diagn. 2019;15(3):159–71.
Zhang C, Luo T, Liu L, Dong H, Hao W. Prevalence rates of personality disorder and its association with methamphetamine dependence in compulsory treatment facilities in China. Front Psychiatry. 2018;9:698.
Article PubMed PubMed Central Google Scholar
Ma CH, Lin KF, Chen TT, Yu YF, Chien HF, Huang WL. Specific personality traits and associated psychosocial distresses among individuals with heroin or methamphetamine use disorder in Taiwan. J Formos Med Assoc. 2020;119(3):735–42.
Loya JM, Tangney JP, Stuewig JB. Are borderline personality disorder features differentially related to pre-incarceration alcohol, cannabis, cocaine, and opioid dependence among people recently incarcerated in jail? J Pers Disord. 2022;36(5):623–40.
Sharma P, Riehm KE, Young AS, Reynolds MD, Tarter RE, Horner MS, et al. Do the transmissible liability index (TLI) and adolescent cannabis use predict paranoid and schizotypal symptoms at young adulthood? Subst Use Misuse. 2021;56(13):2026–34.
Bronchain J, Chabrol H, Raynal P. Could schizotypy protect against the negative outcomes of borderline traits on alcohol consumption? A cluster analytic study Psychiatry Res. 2018;269:21–4.
Gillespie NA, Aggen SH, Neale MC, Knudsen GP, Krueger RF, South SC, et al. Associations between personality disorders and cannabis use and cannabis use disorder: a population-based twin study. Addiction. 2018;113(8):1488–98.
Article PubMed PubMed Central Google Scholar
Spencer M, Miniño A, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief, no 457. [Internet]. Hyattsville, MD: Nat Center Health Stat.; 2022 [cited 2023 Jun 22]. https://www.cdc.gov/nchs/products/databriefs/db457.htm.
Santo TJ, Campbell G, Gisev N, Martino-Burke D, Wilson J, Colledge-Frisby S, et al. Prevalence of mental disorders among people with opioid use disorder: a systematic review and meta-analysis. Drug Alcohol Depend. 2022;1(238): 109551.
Klimas J, Gorfinkel L, Fairbairn N, Amato L, Ahamad K, Nolan S, et al. Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review. JAMA Netw Open. 2019;2(5): e193365.
Article PubMed PubMed Central Google Scholar
Farooqui AM, Arya A, Singh A, Dalal PK. Psychiatric comorbidity, psychosocial problems, and functioning of people who inject opioids: an observational study. Addict Health. 2022;14(3):218–23.
Article PubMed PubMed Central Google Scholar
Nevid JS, Gordon AJ, Barris A, Sperber JE, Haggerty G. Personality profiles of patients with alcohol use disorder and opioid use disorder in an inpatient treatment setting. J Subst Abuse Treat. 2019;97:91–6.
Nichols LM, Pedroza JA, Fleming CM, O’Brien KM, Tanner-Smith EE. Social-ecological predictors of opioid use among adolescents with histories of substance use disorders. Front Psychol. 2021;12: 686414.
Article PubMed PubMed Central Google Scholar
Vest N, Tragesser S. Borderline features and prescription opioid misuse in a substance use disorder treatment sample. Subst Use Misuse. 2019;54(1):166–75.
Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical epidemiology of single versus multiple substance use disorders: polysubstance use disorder. Med Care. 2017;55(9):S24-32.
Dash GF, Martin NG, Agrawal A, Lynskey MT, Slutske WS. Typologies of illicit drug use in mid-adulthood: a quasi-longitudinal latent class analysis in a community-based sample of twins. Addiction. 2021;116(5):1101–12.
• Cougle JR, McDermott KA, Hakes JK, Joyner KJ. Personality disorders and social support in cannabis dependence: a comparison with alcohol dependence. J Affect Disord. 2020;265:26–31. Cross-sectional study using NESARC, which found that people with both alcohol and cannabis dependence had higher rates of PDs and a greater number of PDs than those with either diagnosis alone.
Ellis JD, Pittman BP, McKee SA. Co-occurring opioid and sedative use disorder: gender differences in use patterns and psychiatric co-morbidities in the United States. J Subst Abuse Treat. 2020;114: 108012.
Article PubMed PubMed Central Google Scholar
Trull TJ, Durrett CA. Categorical and dimensional models of personality disorder. Annu Rev Clin Psychol. 2005;1:355–80.
Guillot CR, Lucke HR, Ramsey AJ, Kearns NT, Blumenthal H, Berman ME. Cluster-b personality disorder traits and impulsivity: indirect associations with alcohol use severity through positive alcohol expectancies. Exp Clin Psychopharmacol. 2022.
Poelen EAP, Schijven EP, Otten R. The mediating role of substance use motives in the relationship between personality dimensions and alcohol and drug use in adolescents and young adults with mild intellectual disabilities. Addict Behav. 2022;126: 107173.
Roviš D, Vasiljev V, Jenko-Pražnikar Z, Petelin A, Drevenšek G, Peruč D, et al. Mental health and drug use severity: the role of substance P, neuropeptide Y, self-reported childhood history of trauma, parental bonding and current resiliency. J Ment Health. 2021;30(1):88–96.
• Moraleda E, Ramírez López J, Fernández-Calderón F, Lozano ÓM, Diaz-Batanero C. Personality traits among the various profiles of substance use disorder patients: new evidence using the DSM-5 Section III framework. Eur Addict Res. 2019;25(5):238–47. Cross-sectional study assessing relationships between facets of the Alternative Model for Personality Disorders, substance use disorders, and substance use profiles among
Comments (0)